Although dysregulated microRNAs have been associated with MAPK pathway activation and carcinogenesis, little is known about the role of microRNA-mediated regulation of negative MAPK pathway regulators such as DUSP2 in cancer context [26–28]. This evidence concerns the gene DUSP2 and cancer.